Heteroaromatic compounds as PI3 kinase modulators and methods of use
US9926324B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Nov 10, 2013 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Oct 10, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides heteroaromatic derivatives and pharmaceutical acceptable salts and formulations thereof useful in modulating the protein kinase activity, especially phosphatidylinositol 3-kinases (PI3 kinases) and mTOR, and in modulating inter- and/or intra-cellular signaling activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.